Sensus Healthcare shares are trading higher after the company announced the signing of an exclusive U.S. distribution agreement with Mattioli Eng. Italia for its TransDermal Infusion System non-invasive drug delivery system.

by | Dec 1, 2021 | Uncategorized | 0 comments

Meritas Media Team

Submit a Comment

Your email address will not be published. Required fields are marked *